This study looked at continuous subcutaneous insulin infusions (CSII) for the treatment of diabetic retinopathy (DR; eye disease). It found that compared to multiple daily injections of insulin (MDI), CSII resulted in a less worsening of DR.

This study looked at the risk of urogenital infections in patients with diabetes taking sodium-glucose co-transporter 2 (SGLT2) inhibitors. It found that SGLT2 inhibitors increase the risk of urogenital infections in women over 50 years of age, especially in the first month of treatment.

This review looked at whether antioxidant supplements can reduce inflammation for women with diabetes during pregnancy (gestational diabetes; GDM). It found that supplements including omega-3, vitamin D, and magnesium reduced oxidation in the body for these women.

This study looked at tirzepatide, a new treatment for type 2 diabetes, compared to semaglutide (Ozempic).  It found that, depending on the dose, tirzepatide was similarly or more effective at controlling blood glucose than semaglutide. 

This study compared mecobalamin (vitamin B12) injections with mecobalamin tablets for the treatment of diabetic peripheral neuropathy (DPN; nerve damage). It showed that after 8 weeks of treatment, patients treated with mecobalamin injections showed signs of nerves being repaired, while no effects were seen in those taking the tablets.  

This study evaluated whether liraglutide (Victoza) improves diabetic control in patients with difficult to control type 2 diabetes (T2D) and if there were certain factors that influence the effects of liraglutide. It found that patients responded equally well to liraglutide regardless of body mass index (BMI; a measurement of weight in relation to height), diabetes duration, and other factors.

This study looked at the use of piperazine ferulate (PF) in diabetic patients. It found that adding PF to angiotensin receptor blocker (ARB) treatment helped to protect kidney function in patients with diabetes.

This study looked at the safety and effectiveness of tirzepatide (LY-3298176) in patients with type 2 diabetes (T2D) inadequately controlled by diet and exercise alone. It found that compared to placebo, tirzepatide improved diabetes control and weight in these patients.

This review looked at whether sodium-glucose cotransporter 2 (SGLT2) inhibitors can improve non-alcoholic fatty liver disease (NAFLD) for people with type 2 diabetes (T2D). It found that these medications can improve liver function in these patients.

This long-term study looked at mental sharpness and coordination as adults age with type 1 diabetes (T1D). It found that blood sugar control over the previous 30 years influences later coordination and memory.